UpTrajectory Review
The recent decision by the Trump administration to reschedule medical cannabis from Schedule I to Schedule III could have significant implications for small business operators in the cannabis industry. This change may pave the way for greater tax relief and growth opportunities, particularly if recreational marijuana is also rescheduled in the near future. Operators need to stay informed about potential federal tax considerations and prepare for a shifting regulatory landscape.
For small business owners in the cannabis sector, this development is a double-edged sword. While rescheduling could lead to reduced tax burdens and increased legitimacy, it may also prompt Congress to impose new federal taxes on cannabis. Operators should be proactive in understanding these dynamics and consider how to position their businesses for potential changes in legislation. The landscape is evolving rapidly, and those who adapt quickly will likely benefit the most.
“Would Congress face pressure to consider a federal tax on the budding sector if broader cannabis reform is in the cards?” — Bloomberg Businessweek
Takeaway: Stay informed about cannabis rescheduling and prepare for potential tax changes that could impact your business.
From the original item — Bloomberg Businessweek:
What are the impacts of the Trump administration’s rescheduling of state-licensed medical cannabis to Schedule III from Schedule I? Could federal rescheduling extend to recreational marijuana later this year? If so, how should companies, firms and operators prepare for a world where significant tax relief and growth opportunities emerge? Would Congress face pressure to consider a federal tax on the budding sector if broader cannabis reform is in the cards? Foley Hoag Partner Jeffrey Schultz join